The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a promising breakthrough. Unlike shots, this method offers a less invasive way to provide GLP-1 therapies. These https://mariyahopqn956612.ttblogs.com/20902024/glp-1-patches-a-new-approach-to-glucose-management